1.100CAD0.00%Mkt Cap: 11.48M CADP/E: —Last update: 2026-05-25
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa recepto…
Industry Peers
Drug Manufacturers - Specialty & Generic155.29BSEKP/E 172.0
58.11BTRYP/E 27.8
56.52BEURP/E 22.3
33.63BPLNP/E 21.9
24.50BUSDP/E 21.3
18.90BUSD—
15.76BUSDP/E 24.1
13.30BSEKP/E 40.0
Indicators:|
Key Statistics
Company
Market Cap11.48M CAD
Enterprise Value8.54M CAD
Revenue (TTM)28.86M CAD
Gross Profit11.75M CAD
Net Income (TTM)-7.10M CAD
Revenue/Share2.765 CAD
Last Price1.100 CAD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA58469E4085
Valuation
P/E (Trailing)—
P/E (Forward)-3.55
PEG0.17
EV/EBITDA-1.69
EV/Revenue0.30
P/S0.40
P/B0.89
EPS (TTM)-0.68
EPS (Forward)-0.31
52W Range
0.850043% of range1.430
52W High1.430 CAD
52W Low0.8500 CAD
Profitability
Gross Margin40.71%
Oper. Margin-49.84%
EBITDA Margin-17.54%
Profit Margin-24.60%
ROE-54.98%
ROA-28.45%
Growth
Revenue Growth44.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-560.00K CAD
CapEx (TTM)—
FCF Margin7.62%
FCF Yield19.16%
Net Debt-2.94M CAD
Net Debt/EBITDA0.58
Balance Sheet
Debt/Equity0.07
Current Ratio1.02
Quick Ratio0.74
Book Value/Sh1.237 CAD
Cash/Share0.3670 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateNov 2, 2012
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.10.44M
Float5.28M
Insiders26.87%
Institutions23.10%
Short Interest
Short Ratio2.0d
Short % Float0.03%
Short % Out.0.02%
Shares Short2.53K
Short (prev mo.)2.53K
Technical
SMA 501.136 (-3.2%)
SMA 2001.150 (-4.3%)
Beta0.97
S&P 52W Chg28.31%
Avg Vol (30d)2.21K
Avg Vol (10d)2.14K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—